BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:1676@azbio.org
DTSTART;TZID=America/Phoenix:20220621T080000
DTEND;TZID=America/Phoenix:20220621T090000
DTSTAMP:20220601T223651Z
URL:https://www.azbio.org/events/azbiopeers-tassosgianakakos
SUMMARY:AZBioPEERS: Tales from the Road - Tassos Gianakakos -  - 21 Jun 22 
 08:00
DESCRIPTION:\nTales from the Road   \nTuesday\, June 21st\, 2022   08:00
  – 09:00 AM\n\nFeatured Speaker:\n\n 	 Tassos Gianakakos - CEO\, MyoKar
 dia\n\nPlease join us as Tassos discusses his journey from conception to a
 cquisition. MyoKardia was acquired in 2021 by Bristol Myers Squibb for $1
 3.5 Billion.\n\n&nbsp\;\n\nLocation:  Virtual via Zoom\n\n&nbsp\;\nREGIST
 ER\nAbout Our Speaker\n[caption id="attachment_42864" align="alignleft" wi
 dth="362"] Tassos Gianakakos[/caption]\n\nTassos is a driven executive a
 nd entrepreneur with a proven track-record of successfully starting and
  growing innovative\, science-based companies in the biopharmaceutical in
 dustry.  He’s a values-based leader who has built and developed extrao
 rdinary teams to take on the world’s most challenging health problems. 
  Tassos has a passion for identifying and growing amazing leaders\, bringi
 ng them together to create disruptive change in the field of medicine and 
 improving health outcomes for society.\n\nSince starting in vaccine resear
 ch at Merck &amp\; Co. over 20 years ago\, he has been instrumental in 
 starting-up multiple biotechnology companies focused on creating game-ch
 anging therapies.  Most recently\, he was CEO of MyoKardia\, a mission-dr
 iven company focused on changing the lives of people with serious cardiova
 scular disease through bold and innovative science.  MyoKardia pioneered 
 a precision medicine approach to discovering and development novel therapi
 es for heart conditions and was acquired by BMS in October of 2021 for $13
 .5 billion.\n\nTassos and his wife Katina grew up in Chicago and currently
  live with their three boys in Paradise Valley.  He has an engineering an
 d economics degree from the Massachusetts Institute of Technology\, a gr
 aduate degree in biotechnology from Northwestern University\, and an MBA
  from Harvard Business School.  Tassos is currently on the board of Lia
 nBio (NASDAQ: LIAN) a leading cross-border biotechnology company on a miss
 ion to bring transformative medicines to historically underserved patients
  in Greater China and other Asian markets. He is a regular speaker at biot
 echnology industry events and as an alumni adviser to MIT\, Northwestern a
 nd Harvard Business School.\n\n&nbsp\;
CATEGORIES:AZ - Central
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20210621T080000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR